Related Experiment Videos
The importance of Mycobacterium bovis as a zoonosis
Charles Thoen1, Philip Lobue, Isabel de Kantor
1Department of Veterinary Microbiology and Preventative Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA. cthoen@iastate.edu
Abstract:
Mycobacterium bovis and closely associated acid-fast bacilli cause disease in humans. Epidemiologic investigations reveal that the organism may be ingested or inhaled. Extra pulmonary lesions may occur associated to the consumption of infected milk, even though with the practice of boiling milk, and the growth of milk pasteurization plants all over the world, the digestive route of infection became less important. On the other hand, airborne infection continues to occur among meat industry and slaughterhouse workers, in regions where the infection is still prevalent in cattle. Evidence of person to person transmission is rare. Main causes of concern related to M. bovis in industrialized countries are: epizootics in domesticated and wild mammals and latent infection in immigrants. Although multidrug-resistant (MDR) strains of M. bovis have been identified, case reports reveal that anti-tuberculosis drugs routinely used to treat Mycobacterium tuberculosis-infected patients are effective when properly administered.
Insights
Mycobacterium bovis causes human disease primarily through inhalation, especially in meat industry workers. While multidrug-resistant strains exist, standard tuberculosis drugs remain effective for treatment.
Area of Science:
- Microbiology
- Epidemiology
- Public Health
Background:
- Mycobacterium bovis and related bacteria cause human infections.
- Transmission occurs via ingestion or inhalation.
Observation:
- Milkborne transmission has decreased due to pasteurization.
- Airborne transmission remains a risk for slaughterhouse workers.
- Person-to-person spread is infrequent.
Findings:
- Epizootics in mammals and latent infections in immigrants are key concerns in industrialized nations.
- Multidrug-resistant (MDR) Mycobacterium bovis strains are documented.
- Standard anti-tuberculosis drugs are effective against M. bovis when administered correctly.
Implications:
- Public health strategies should focus on controlling bovine tuberculosis and managing occupational risks.
- Continued surveillance for MDR strains is necessary.
- Effective treatment protocols exist for M. bovis infections.
Related Concept Videos
Toxoplasmosis
Tuberculosis
Clinical Significance of Antibiotic Resistance
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Infectious Diseases and Their Occurrence
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...